Walleye Capital
GILD icon

Walleye Capital’s Gilead Sciences GILD Stock Holding History

Walleye Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21M Buy
150,967
+127,817
+552% +$17.9M 0.09% 179
2025
Q4 		$2.84M Buy
23,150
+8,383
+57% +$1.02M 0.01% 1580
2025
Q3 		$1.64M Sell
14,767
-1,817
-11% -$207K 0.01% 1726
2025
Q2 		$1.84M Buy
+16,584
New +$1.76M 0.01% 1580
2025
Q1 		– Sell
-5,404
Closed -$558K – 4559
2024
Q4 		$499K Sell
5,404
-8,382
-61% -$755K ﹤0.01% 2984
2024
Q3 		$1.16M Sell
13,786
-86,379
-86% -$6.59M ﹤0.01% 2505
2024
Q2 		$6.87M Buy
100,165
+99,490
+14,739% +$6.64M 0.01% 1039
2024
Q1 		$49.4K Buy
+675
New +$51.9K ﹤0.01% 4681
2021
Q1 		– Sell
-13,688
Closed -$797 – 1234
2020
Q4 		$797 Buy
+13,688
New +$826K 0.05% 345
2020
Q2 		– Sell
-380
Closed -$28K – 747
2020
Q1 		$28K Sell
380
-360
-49% -$24.9K 0.01% 734
2019
Q4 		$48K Sell
740
-29,989
-98% -$1.95M ﹤0.01% 1507
2019
Q3 		$1.95M Buy
30,729
+30,129
+5,022% +$1.97M 0.12% 230
2019
Q2 		$41K Buy
600
+110
+22% +$7.24K ﹤0.01% 1417
2019
Q1 		$32K Buy
+490
New +$32.6K 0.01% 1288

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Walleye Capital's GILD Position: Q1 2026 in Review

Walleye Capital increased its Gilead Sciences (GILD) stake by 552% in Q1 2026, buying an estimated $17.9M and bringing the position to 150,967 shares worth $21M. The position accounts for 0.09% of the portfolio, ranked #179.

Walleye Capital first reported a position in GILD in Q1 2019 and has held it in 14 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Walleye Capital held 150,967 shares of Gilead Sciences worth $21M as of Q1 2026.
  • Walleye Capital bought 127,817 Gilead Sciences shares in Q1 2026, an estimated $17.9M.
  • Gilead Sciences made up 0.09% of Walleye Capital's portfolio in Q1 2026, its #179 holding.
  • Walleye Capital first reported a position in Gilead Sciences in Q1 2019 and has held it in 14 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.